The shared pathologies, such as the presence of amyloid-beta in drusen in AMD patients, and common risk factors, including aging and genetic variants in CFH and ApoE4 in AMD and Alzheimer’s disease, suggest potential overlap in disease pathogenesis. This evidence concerns the gene APOE and age-related macular degeneration.